Mark Asbill

Clinical Research Associate at Advanced Clinical - Deerfield, Illinois, US

Mark Asbill's Colleagues at Advanced Clinical
Donna Hanson

Corporate Development Director

Contact Donna Hanson

Lindsey Maurer

In-House Clinical Research Associate

Contact Lindsey Maurer

Steven Ross

Director Business Development

Contact Steven Ross

Dayna Geralts

Senior Project Manager

Contact Dayna Geralts

Rachel Thiel

Senior Project Data Manager

Contact Rachel Thiel

View All Mark Asbill's Colleagues
Mark Asbill's Contact Details
HQ
(847) 267-1176
Location
United States
Company
Advanced Clinical
Mark Asbill's Company Details
Advanced Clinical logo, Advanced Clinical contact details

Advanced Clinical

Deerfield, Illinois, US • 1114 Employees
Major Drugs

Advanced Clinical is a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey. Our goal is to improve the lives of all those touched by clinical research – approaching each opportunity with foresight, character, resilience and innovation. Based on decades of experience, we help our clients achieve better outcomes by conducting candid conversations and anticipating potential issues through our customized solutions. Visit our website to learn more: www.advancedclinical.com.

Drug Development And Manufacturing Clinical Research Clinical Trial Clinical Data Management Regulatory Affairs Pharmacovigilance
Details about Advanced Clinical
Frequently Asked Questions about Mark Asbill
Mark Asbill currently works for Advanced Clinical.
Mark Asbill's role at Advanced Clinical is Clinical Research Associate.
Mark Asbill's email address is ***@advancedclinical.com. To view Mark Asbill's full email address, please signup to ConnectPlex.
Mark Asbill works in the Major Drugs industry.
Mark Asbill's colleagues at Advanced Clinical are Donna Hanson, Lindsey Maurer, Steven Ross, Dayna Geralts, Sheri Edwards, Rachel Thiel, Karli Bryant and others.
Mark Asbill's phone number is (847) 267-1176
See more information about Mark Asbill